MEETING REVIEW |
IMCAS 2012 SUPPORTING MEDICAL
T HE IMCAS PARIS
Annual Meeting is one of the most important European congresses dedicated to plastic surgery and cosmetic
dermatology. Its main objective is to promote high standards in clinical practice, education and research within the plastic surgery/dermatology arena, as well as in related disciplines. This year's meeting was no different
and proved very successful. It was conducted by Benjamin Ascher, French Board-certified Plastic Surgeon and IMCAS Scientific Director; David J Goldberg, Dermatologist (US); Bernard Mole, Plastic Surgeon (France); and Bernard Rossi, Dermatologist, (France); as well as scientific secretaries, Olivier Gerbault, Plastic Surgeon (France); Anne Le Pillouer Prost, Dermatologist (France); and Serge Mordon, PhD, Research (France).
Record-breaking attendance This year's event welcomed 330 key opinion leaders from across the globe, more than 4000 delegates, more than 160 exhibitors, and 100 accredited journalists, generating a buzz with 90 press reviews.
Injectables Cadaver Workshop was held, dedicated to anatomical considerations for toxins and fillers. A Breast Lipofilling Workshop was also aired using live video satellite between the operating room from Lyon and the Palais des Congress of Paris, with an exciting round table to establish the European guidelines and rules of this fat injection technique.
This year's event welcomed 330 key opinion
leaders from across the globe, more than 4000 delegates, more than 160 exhibitors, and 100 accredited journalists.
IMCAS 2012: ensuring vigilance Far from lectures and conference talks, the programmeÔs theme was 'controversy'. A great deal of scientific sessions were devoted to the topic of complications and techniques for their prevention, while others focused on the themes of cosmeto- and materio-vigilance alerts. In short, IMCAS did not wait for the PIP crisis to make vigilance one of its main concerns by organising the following sessions: ■ Comparisons of hyaluronic acids, toxins and lasers, as well as breast implants
■ Filler complications,
featuring the results of the first worldwide survey in this area
■ Operative safety in surgical dermatology and plastic surgery
A world premiere at IMCAS Two brand new courses took the form of live video conferences, using cutting-edge technology to allow attendees to witness procedures and connect with practitioners. Live from the school of surgery of Fer ΠMoulin, Paris, a fully interactive IMCAS
108 ❚ March 2012 |
prime-journal.com
■ European vigilance in dermatologic and surgical aesthetics
■ A full session dedicated to the PIP crisis was later added.
2012 developments Techniques and products are becoming more and more efficient, especially with regard to the face, which does not exclude
VIGILANCE AND INNOVATION
PRIME reviews the 14th annual IMCAS conference, held in January 2012, which certainly proved a conference to remember
an increased vigilance to optimise the costÐ benefit ratio. Wrinkle fillers, volumising products and botulinum toxins are a good example; the enforcement of controls regarding market entrance authorisation are already efficient for most, but there remains a need for clinical studies prior to introduction to the market in order to limit the risks and misuses. Throughout 2012, the market is expected
to experience a two-shift growth, characterised by a growth of approximately 5% in Europe, compared with 2011, and a growth of approximately 15% in Asia. Cosmeceuticals will follow this growth trend, and classic techniques (e.g. peelings, lasers, radiofrequency) are beginning to catch up with the decrease of business previously seen in this area. With regard to the body, the controls and
studies of remodelling devices and medical slimming products have to get through the same process as the face; the suspension of fat lysing methods being only a temporary solution, will lead to good processes with a better documentation. On the surgical aspect, the slowdown expected in Europe is limited. Breast implants are subject to a progression of approximately 6%, in line with data from previous years. The general progression for surgery also presents a shift: +7% in Europe against +11.1% in the US and +15.7% in Asia. The two most popular interventions remain liposuction and breast augmentation.
2011 trends ■ The natural look. Throughout Europe and the USA, the trend is now to restore and maintain patients' beauty, without the need to 'look young at any cost'
■ Localised surgical lifting. Whether for the face, arms or internal thighs, lifting
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112